Sun, C.; Wang, J.; Xia, T.; Sun, Q.; He, Y.; Wang, H.; He, Q.; Liu, L.
Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway. Pharmaceuticals 2022, 15, 1589.
https://doi.org/10.3390/ph15121589
AMA Style
Sun C, Wang J, Xia T, Sun Q, He Y, Wang H, He Q, Liu L.
Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway. Pharmaceuticals. 2022; 15(12):1589.
https://doi.org/10.3390/ph15121589
Chicago/Turabian Style
Sun, Changzhen, Jianv Wang, Tong Xia, Qin Sun, Yijing He, Hailan Wang, Qizhou He, and Li Liu.
2022. "Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway" Pharmaceuticals 15, no. 12: 1589.
https://doi.org/10.3390/ph15121589
APA Style
Sun, C., Wang, J., Xia, T., Sun, Q., He, Y., Wang, H., He, Q., & Liu, L.
(2022). Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway. Pharmaceuticals, 15(12), 1589.
https://doi.org/10.3390/ph15121589